clock menu more-arrow no yes mobile

Filed under:

Michal Oleksiejczuk gets one-year suspension, win overturned for UFC 219 drug test failure

Michal Oleksiejczuk has been suspended for one year.
Esther Lin, MMA Fighting

Michal Oleksiejczuk’s second UFC fight will have to wait.

Oleksiejczuk was issued a one-year suspension Tuesday by the Nevada Athletic Commission (NAC) stemming from his failed drug test in relation to his Octagon debut at UFC 219. Oleksiejczuk tested positive in an in-competition drug screening ahead of the Dec. 30 bout, which initially saw him defeat Khalil Rountree via unanimous decision. Oleksiejczuk popped for the anti-estrogen agent clomiphene, a commission official told MMA Fighting.

In addition to the one-year suspension, Oleksiejczuk was fined $3,600 — 30% of his $12,000 purse — and will be required to submit a clean drug test before seeking relicensure. The Polish light heavyweight’s win over Rountree has also been overturned into a no-contest.

Oleksiejczuk joins a growing list of UFC athletes to test positive for clomiphene, a list which includes the likes of Jon Jones, Brock Lesnar, Jesse Taylor, and Nick Roehrick.

USADA still has yet to rule on the 23-year-old’s case, so Oleksiejczuk could potentially face further sanctions from the UFC’s drug-testing partner.

Oleksiejczuk (12-2, 1 NC) was initially scheduled to make his Octagon debut against Ion Cutelaba at UFC 217, however that fight was scrapped after Cutelaba suffered his own USADA violation.

Oleksiejczuk’s one-year NAC suspension ends on Dec. 30.

Sign up for the newsletter Sign up for the MMA Fighting Daily Roundup newsletter!

A daily roundup of all your fighting news from MMA Fighting